The association between uric acid levels and renal function of CKD patients with hyperlipidemia: a sub-analysis of the ASUCA trial.

Yoshihiro KuwabaraShinji YasunoMasato KasaharaKenji UeshimaKazuwa Nakao

Published in: Clinical and experimental nephrology (2019)

In CKD patients with dyslipidemia, hyperuricemia was an independent risk factor for CKD progression. An ongoing clinical trial (TARGET-UA, UMIN-ID 000,026,741) may reveal the significance of strict UA-lowering therapy in CKD patients.

Keyphrases

chronic kidney disease
end stage renal disease
uric acid
clinical trial
metabolic syndrome
phase ii
newly diagnosed
ejection fraction
study protocol
type diabetes
peritoneal dialysis
high fat diet
genome wide
open label
stem cells
gene expression
bone marrow